✓ Medically reviewed by Dr. Anjmun Sharma, MD · Updated 2026-06-024 min read

Does Medicare Cover GLP-1 Weight-Loss Medication?

Medicare's rules on GLP-1s are specific and often misunderstood. Here is the honest picture.

A bright, calm home workspace with natural light, set up for a video visit

The short answer

By law, Medicare Part D has historically not covered medications used for weight loss alone. It can cover a GLP-1 when it is prescribed for an approved non-weight indication, for example semaglutide or tirzepatide for type 2 diabetes, or Wegovy for reducing cardiovascular risk in eligible patients after its 2024 approval for that use. Coverage and rules can change, so verify with your specific plan.

Why this confuses people

The same active ingredient can be covered or not covered depending on the diagnosis and the brand's approved indication. Diabetes or an approved cardiovascular indication may be covered; "for weight loss" alone generally is not, under current Part D rules. Always check your individual plan's formulary.

Ready to start?

$199 Skeptics’ Trial, see if it works for you

One month of medical-grade compounded semaglutide, the $119 doctor review, and a free B-12/lipotropic injection. No long-term commitment.

Start the 30-day trial

What your options are

If Medicare will not cover a GLP-1 for weight, options include discussing whether you have a covered indication, looking at brand manufacturer programs, or considering cash-pay physician-supervised compounded medication. A physician and your plan documents are the accurate sources, not a general article.

How this relates to what we offer

We are a cash-pay, transparent-price clinic: a $119 review and compounded semaglutide from $166 a month or tirzepatide from $233, which can be predictable when insurance will not cover weight treatment. We never bill Medicare for weight-loss medication.

What you can start today at New Hope Weight Loss

After a one-time $119 medical review with Dr. Sharma, eligible patients begin physician-supervised compounded semaglutide from $166 a month or compounded tirzepatide from $233 a month, with a $199 one-month Skeptics' Trial. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality. In person in Orange County and by telehealth across California and additional states.

Ready for an honest, physician-supervised plan?

A $119 review with Dr. Sharma is the first step, no pressure. Take the 2-minute quiz or call us.

Call (657) 837-3342

Frequently asked questions

Does Medicare cover Ozempic or Wegovy for weight loss?

Medicare Part D generally does not cover GLP-1s for weight loss alone. It may cover them for an approved indication like type 2 diabetes, or Wegovy for cardiovascular risk reduction in eligible patients. Check your specific plan.

Why won't Medicare pay for weight-loss drugs?

A longstanding federal rule has excluded drugs used only for weight loss from Part D coverage. Rules can change, so verify your plan's current formulary.

Can I get a GLP-1 covered if I have diabetes?

Often yes, if it is prescribed for type 2 diabetes and on your plan's formulary. Coverage depends on diagnosis and plan; confirm with your plan and physician.

What if Medicare won't cover it?

Options include checking for a covered indication, brand manufacturer programs, or cash-pay physician-supervised compounded medication with transparent pricing.

Does New Hope bill Medicare?

No. We are a cash-pay clinic with transparent prices: a $119 review and compounded semaglutide from $166/mo or tirzepatide from $233/mo. We do not bill Medicare for weight medication.

This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.

Not ready to start? Get the details by email.

Pricing, how it works, and what to expect, sent to your inbox. No pressure, unsubscribe anytime.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.